What Streuli Pharma does

Streuli Pharma AG is a privately held Swiss pharmaceutical manufacturer founded in 1867 and headquartered at Bahnhofstrasse 7 in Uznach (canton St. Gallen). The company produces prescription medications, specialty pharmaceuticals, generics, cosmetics, and dietary supplements at its single Uznach facility, where approximately 200 employees manufacture roughly 80 percent of the products in-house — yielding annual output of about 150 million tablets and capsules, 4 million ampoules, and various galenic forms (ointments, gels, suppositories). The portfolio covers analgesics, NSAIDs, corticosteroids, dermatologicals, cardiovascular, gastrointestinal, respiratory, urological, vitamin supplements, and CNS medications, plus a dedicated Dental line (notably the Rudocain local-anesthetic franchise) and Veterinary products.

The company operates a vertically organized, B2B sales-led go-to-market targeting physicians, dentists, hospitals, and pharmacies throughout Switzerland, with end-patient consumption downstream of those channels. All branded SKUs carry the 'Streuli' suffix and several legacy names (Acetalgin, Vitarubin, Dentohexin, Rudocain) function as standalone sub-brands; products are also discoverable via listing on the official Swiss Compendium drug reference. Revenue mechanics are standard pharma product sales (one-time licensing/purchase transactions through Swiss distribution), with pricing not publicly disclosed.

Ownership and governance are family-controlled: the company is in its fifth generation of family ownership and led by Claudia Streuli (Eidg. dipl. Apothekerin ETH) as Executive Chairwoman of the Board. Streuli Pharma AG operates as a Swiss Aktiengesellschaft (corporation) with no parent company, no subsidiaries, no institutional investors, and no disclosed M&A history. Operating status is active with ongoing recruitment, and the company's geographic footprint is exclusively Switzerland.

Name

Streuli Pharma

Legal name

Streuli Pharma AG

Website

https://streuli-pharma.ch

Company type

Private

Founded year

1867

Operating status

Operating

Headcount range

51–100 employees

Short description

Streuli Pharma AG is a Swiss family-owned pharmaceutical manufacturer founded in 1867 in Uznach, producing branded and generic prescription medications, dental anesthetics, and veterinary products exclusively for the Swiss healthcare market from its single-site facility.

Ownership category

akta.pro rank

Product category

Generic and specialty pharmaceutical manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Generic Hospital & Institutional Products (HLAIABAL), Generic & Private-Label Veterinary Pharmaceuticals (HLAMAEAM)

Keywords

• Generic pharmaceutical manufacturing
• Prescription drug production
• Dental pharmaceutical products
• Veterinary pharmaceuticals
• Dietary supplement manufacturing

Headquarters

HQ city

Uznach

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Streuli Pharma generates revenue through the production and distribution of proprietary specialty pharmaceuticals and generic products for human, dental, and veterinary applications. The company sells prescription medications, cosmetics, and dietary supplements through Swiss pharmaceutical distribution channels.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Streuli Pharma AG manufactures and distributes a comprehensive portfolio of proprietary specialty and generic pharmaceutical products for human, dental, and veterinary applications. The company produces prescription medications, over-the-counter products, cosmetics, and dietary supplements in multiple dosage forms including tablets, capsules, ampoules, ointments, gels, and suppositories. Approximately 80% of the product range is manufactured at the company's headquarters in Uznach, Switzerland.

Product overview

Streuli Pharma AG is a Swiss pharmaceutical company with over 150 years of history that produces and distributes a comprehensive portfolio of medications across three main therapeutic areas: Human, Dental, and Veterinary. The company operates as a single unified product portfolio rather than a platform-plus-modules architecture. Their Human product range includes proprietary specialty medications and generic products (manufactured since 1971), organized into therapeutic categories: analgesics (Acetalgin®, Mefenacid®, ASA-Tabs®), corticosteroids (Prednisolon Streuli®, Prednison Streuli®), dermatological products (Bitumol®, Kamillex®, Pantothen-Streuli®, Vita-Hexin®), gout therapeutics (Uriconorm®, COLCTAB®), cardiovascular medications (Cinnageron®, Ephedrin Streuli®, Nitroglycerin Streuli®), local anesthetics (Lidocain Streuli®), gastrointestinal drugs (Loperamid Streuli®, Pantoprazol Streuli®, Prontolax®, Rudolac®), respiratory medications (Cetirizin Streuli®, Emedrin® N, Rinosedin®), urological products (Tamsulosin Streuli®), vitamin supplements (Vitarubin® variants, B1/B2/B6 Streuli®, Vitamin D3 Streuli®), CNS medications (Zolpidem Streuli®, Aphenylbarbit), and opioids (Hydromorphoni HCI Streuli®, Methadon Streuli®, Morphini HCI Streuli®). The Dental portfolio includes local anesthetics (Rudocain®, Rudocain® forte), analgesics (Mefenacid®, Acetalgin®), and oral care products (Dentohexin®, Angina MCC®). The company also produces cosmetics and nutritional supplements. Approximately 80% of products are manufactured at the Uznach facility, with annual production of around 150 million tablets and capsules, 4 million ampoules, and various galenic forms.

Differentiator

Problem solved

Functional benefit

Brands

• Streuli: Pharmaceutical products including prescription medications, generics, cosmetics, and dietary supplements for human use.
• Rudocain
• Acetalgin
• Mefenacid
• Dentohexin
• Vitarubin

Products and services

• Human Pharmaceuticals (proprietary and generic)
• Dental Pharmaceuticals
• Veterinary Pharmaceuticals
• Cosmetics
• Dietary Supplements

Named customers5 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators5 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Almirall S.A. European specialty pharmaceutical company focused on dermatology and primary care prescription products. Comparable in branded specialty positioning and HCP-led GTM, though larger and operating across multiple European markets.
• Sandoz International GmbH: Global generics leader headquartered in Basel, Switzerland. Comparable in generics manufacturing and Swiss regulatory exposure, but vastly larger scale and global footprint versus Streuli's domestic-only model.
• Stada Arzneimittel AG: European generics and specialty pharma group operating across multiple European markets. Comparable in generics/specialty mix and pharmacy-channel GTM, but materially larger and geographically broader than Streuli.
• Teva Pharmaceutical Industries Ltd. Global generics leader with a Swiss commercial entity (Teva/Mepha). Comparable in generics portfolio and Swiss pharmacy-channel distribution, but orders of magnitude larger than Streuli and operates across all major geographies.
• Recordati S.p.A. European specialty pharmaceutical company with established brands across cardiovascular, urology, and primary care. Comparable therapeutic breadth and specialty pharma orientation, but with broader European footprint than Streuli.

Regional players

• Galexis AG: Leading Swiss pharmaceutical wholesaler and distributor serving pharmacies, hospitals, and physicians. Comparable Swiss pharma channel exposure and domestic reach; functions as a likely downstream partner/customer for Streuli rather than a direct competitor.

Direct peers

• Gebro Pharma AG: Swiss-headquartered specialty pharmaceutical company with branded prescription products in pain, CNS, and respiratory. Comparable mid-sized Swiss pharma with similar therapeutic breadth and physician/pharmacy channel mix.
• Hänseler AG: Swiss pharmaceutical manufacturer and compounder supplying hospitals, pharmacies, and industry with specialties and galenics. Comparable in scale, Swiss-domestic orientation, and product mix including ampoules and galenic forms.
• Mepha Pharma AG: Swiss generics-focused pharmaceutical company selling through pharmacies and physicians across Switzerland. Directly comparable to Streuli's generics franchise with similar regulatory exposure to Swissmedic and BAG pricing.
• Spirig HealthCare AG: Swiss specialty and generic pharmaceutical manufacturer serving dermatology, cardiometabolic, and OTC categories. Closely comparable to Streuli as a mid-sized Swiss pharma producer with a hybrid branded/generic portfolio and similar HCP distribution model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/113268147195830

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Streuli Pharma